Need all Congresses? Press Enter for expanded federal results.

SB 2544

Mississippi Senate bill in Session 2026.

Status: failed. Latest action: February 3, 2026.

Mississippi Active Pharmaceutical Ingredient Quality Assurance Act; enact to impose certain provisions for compounding.

Bill ID MS-2026-SB-2544
Session 2026
Status failed
Committee Public Health and Welfare
Senate failed 2026-02-03
Summary

AN ACT TO CREATE THE "MISSISSIPPI ACTIVE PHARMACEUTICAL INGREDIENT QUALITY ASSURANCE ACT" WITHIN CHAPTER 21, TITLE 73, MISSISSIPPI CODE OF 1972; TO PROVIDE THAT IT IS UNLAWFUL FOR ANY PERSON OR ENTITY TO ENGAGE IN THE SALE, TRANSFER OR DISTRIBUTION OF A DRUG COMPOUNDED UNDER SECTION 503A OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT UNLESS THE COMPOUNDER OF THE DRUG SATISFIES CERTAIN REQUIREMENTS AND STANDARDS RELATING TO BULK DRUG SUBSTANCES; TO SET FORTH PENALTIES FOR VIOLATIONS OF THIS ACT; TO REQUIRE PERSONS OR ENTITIES ENGAGING IN THE SALE, TRANSFER OR DISTRIBUTION OF COMPOUNDED DRUGS TO MAINTAIN ALL RECORDS RELATED TO THE ACQUISITION, EXAMINATION AND TESTING OF THE BULK DRUG SUBSTANCE FOR AT LEAST TWO YEARS AFTER THE EXPIRATION DATE OF THE LAST LOT OF DRUG CONTAINING THE BULK DRUG SUBSTANCE; TO AUTHORIZE THE BOARD OF PHARMACY TO PERFORM INSPECTIONS FOR COMPLIANCE WITH THIS ACT AND TO PROMULGATE RULES AND REGULATIONS NECESSARY TO IMPLEMENT THIS ACT; AND FOR RELATED PURPOSES.

Sponsor
Joey Fillingane
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-01-19 Introduced Bill introduced
2026-02-03 Status failed
2026-02-03 Latest Action (S) Died In Committee
More Bills From This Sponsor